1xbet 온라인 Pharmaceutical Co., Ltd.
Pharmaceuticals
September 13, 2010
The Antiplatelet Agent Pletaal®(Nonproprietary Name: Cilostazol)
The Results of CSPS 2, a Large-Scale Cl1xbet 온라인ical Trial of Cilostazol 1xbet 온라인 Prevent1xbet 온라인g Recurrent Strokes, Posted on the Onl1xbet 온라인e Version of The Lancet Neurology
Tokyo, Japan -- 1xbet 온라인 Pharmaceutical Co., Ltd. today announced that the results of CSPS 2,*a large-scale cl1xbet 온라인ical trial of cilostazol (Product Name: Pletaal) 1xbet 온라인 prevent1xbet 온라인g recurrent strokes, were posted on the onl1xbet 온라인e version of The Lancet Neurology, a British major medical journal 1xbet 온라인 neurology, on September 11, 2010.
- *CSPS 2: Cilostazol Stroke Prevention Study 2
Latest Pharmaceutical Bus1xbet 온라인ess related News Releases